Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Finasteride before TURP reduces blood loss and slightly improves early postoperative quality of life.

Imaging intestinal stem cells might help detect early signs of colorectal cancer.

Dapagliflozin helps protect heart cells under stress by improving mitochondrial function and reducing cell damage.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Hair follicle stem cells can help heal intestinal injuries in rats.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Urinary PSA could be an early marker for enlarged prostate.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Some patients fail bladder function tests due to lower flow rates and higher remaining urine volumes, but the exact reasons for failure are unclear.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Hair loss linked to prostate enlargement; stress and family history important factors.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

The VSCAPSI is a helpful method for evaluating the severity of scalp psoriasis.

Neurosteroids are crucial for stress response, and targeting specific receptors may help treat certain disorders.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Ovarian and stress hormones can change GABA A receptors through neurosteroids.

Stem cells are crucial for skin repair and new treatments for chronic wounds.

Microtechnology methods improve organoid production for medical research.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.